THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Founder & CEO

Clinical resource

The Patients Missing From the Success Rate: Why Treatment Dropout Belongs in the Headline

A major psychotherapy review estimated 19.7% premature discontinuation. Explore how missing follow-up, completion definitions and patient choice change the meaning of treatment success.

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

A success rate can look reassuring while leaving important people outside the calculation: those who stopped attending, left treatment early, or could not be reached afterward. Their experiences are not all the same. But a report that does not explain their absence may describe the easiest patients to measure rather than everyone the service treated.

Key findings

19.7%: weighted estimate of adult-psychotherapy dropout in a 2012 meta-analysis.

669 studies and 83,834 clients: the evidence included in that review.

18.7% to 20.7%: the 95% confidence interval around the pooled estimate. This is historical research, not a 2026 national rate or a prediction for every clinic. [1]

44,957 patients: a 2026 NHS study illustrating that planned discharge and clinical recovery can move in different directions. [2]

Almost one in five, but not one universal rate

Historical pooled estimate of adult-psychotherapy dropout2012 meta-analysis: 19.7 percent, with a 95 percent confidence interval of 18.7 to 20.7 percent. The bar starts at zero on a 100 percent scale. This is not a current single-service rate.Adult psychotherapy, 2012 meta-analysisWeighted dropout rate19.7%95% confidence interval: 18.7% to 20.7%050100%

The interval describes uncertainty around the pooled estimate, not the range of results across all studies. Source: Swift and Greenberg, 2012. [1]

The review found variation by dropout definition, setting, diagnosis, and other study characteristics. Its value is in showing that premature discontinuation is substantial and measurable, not in supplying one timeless number for every treatment.

Its complement is not a recovery rate. Remaining in treatment does not establish that symptoms improved. Equally, leaving an episode early does not explain what happened next.

Four numbers that should never be merged

Attendance, completion, improvement, and follow-up answer different questions
MeasureWhat it showsWhat remains unknown
AttendanceAppointments attendedWhether treatment helped
CompletionA defined episode was completedWhether recovery occurred
Clinical outcomeChange on a specified health measureWhat caused the change without a suitable study
Follow-up responseWho provided later informationHow nonrespondents were doing

A service may perform well on one measure and less well on another. That is not a contradiction. It is a reason to report them separately instead of calling the most favorable percentage a general success rate.

A family should also ask whether the measures describe the same people. A completion count from one year and an outcome survey from a different group do not automatically form a single patient pathway.

Engagement and recovery can move apart

A February 2026 observational study examined 44,957 patients across seven NHS Talking Therapies services. Physical long-term conditions were associated with higher odds of planned discharge but lower odds of reliable recovery. [2]

The finding does not prove that a physical condition caused a particular result. It demonstrates why a person staying engaged and a person meeting a clinical endpoint are distinct outcomes.

For private care, the implication is practical. A patient attending every session may still need reassessment, a different treatment component, or help with another condition. Completion deserves attention, but it cannot stand in for the clinical result.

Not every early ending means the same thing

A person may transfer, agree that another approach is more appropriate, stop for practical reasons, or decline further treatment. These are possible categories to investigate, not explanations to assign without evidence.

A useful record distinguishes an accepted transfer from unexplained loss of contact. It documents the reason where known and recognizes that the clinician’s view of completion may differ from the patient’s.

The solution is not to relabel every early departure as a planned ending. That would protect a percentage at the expense of useful information. Nor should every departure automatically be described as deterioration.

Annual totals do not necessarily track one group

NHS England’s 2025/26 annual report notes that referral, access, and completion totals do not all relate to the same referral cohort. Dividing one total by another can therefore fail to measure the dropout rate readers assume it represents. [3]

The same rule applies to private reporting. Does the report follow everyone admitted during a period, everyone discharged, or a fixed group observed over time? Each design can be useful, but the starting population must be clear.

A graphic showing stages of care should follow compatible people and periods. Otherwise, an apparent loss between stages may reflect different reporting groups rather than patients dropping out.

Missing follow-up is unknown, not a convenient result

Counting everyone lost to follow-up as recovered is misleading. Declaring every missing response a failure is also not an observed result.

A careful report states what was measured and examines how reasonable assumptions about missing outcomes affect the conclusion. The method should not be changed afterward to produce the most attractive percentage.

In a small private cohort, a few missing observations can materially change a rate. Exact counts and clear limitations may be more informative than an extra decimal place. Reporting also needs to protect people who might be identifiable in small subgroups.

For international clients, follow-up needs a practical plan

A person treated abroad may return home before follow-up is due. That creates a logistical question, not evidence of recovery or relapse. The pathway should specify who makes contact and what the receiving clinician has agreed to do.

For someone moving between the UK, the United States, Europe, or the Gulf, arrangements should reflect the relevant professional and legal requirements. An assumption that remote care works identically everywhere is not a care plan.

Financial resources may support travel and flexible appointments without removing every barrier to participation. Ask what arrangement the patient can realistically use, how consent is handled, and what happens after a missed contact.

Better engagement must not become pressure to stay

Reducing avoidable dropout is a reasonable service aim. It should not pressure someone to remain in a program regardless of clinical need or preference.

NICE recommends discussing treatment preferences, previous experiences, and barriers to engagement in depression care. That is more useful than assuming a person who leaves lacks motivation. [4]

Questions about timing, communication, expectations, and treatment fit can identify improvements. The patient’s explanation should inform the assessment. A retention target should support consent-based care rather than override it.

What families should see before admission

A proposed disclosure checklist for treatment outcomes
DisclosureWhy it matters
Completion and dropout definitionsPrevents unlike rules from appearing comparable
Counts at each stageShows who contributes to each percentage
Reason for endingSeparates transfers, agreed endings, and lost contact
Clinical status at endingDistinguishes attendance from improvement
Follow-up coverageShows how much of the later picture was observed
Missing-data approachExplains uncertainty in the result

The admissions discussion should also explain review points and circumstances in which the plan might change. Financial terms belong in a clear agreement, not in the clinical definition of successful completion.

A family member or payer may help, but that does not automatically create unrestricted access to clinical information. The person receiving care should know how concerns can be raised and how decisions will be made.

This checklist is a reporting proposal. It is not an audit of private providers or a THE BALANCE retention claim.

What the numbers cannot tell us

The historical 19.7% estimate is not the current rate for every therapy. The 2026 association does not establish causation. Neither supplies a private-clinic comparison. A proper provider evaluation would need a defined cohort, reconciled records, transparent exclusions, and consistent outcome measures.

The bottom line

Ask who is absent from the success rate. A service that explains its missing data may offer a more useful evidence record than one displaying a higher percentage without the underlying counts. The objective is appropriate treatment and honest follow-up, not keeping every patient in the original program at any cost.

For journalists

Key number: 19.7% weighted dropout in a 2012 review of 669 adult-psychotherapy studies.

Current comparison: a 2026 NHS study found that engagement and recovery could differ for patients with physical long-term conditions.

Suggested attribution: THE BALANCE analysis of published psychotherapy and outcome-reporting research.

Methodology and sources

This narrative analysis preserves the historical review’s date and confidence interval. It combines that evidence with a separate observational study and official guidance. No new pooled dropout estimate or provider score was calculated.

  1. Swift and Greenberg. Premature discontinuation in adult psychotherapy: a meta-analysis. 2012.
  2. Verbist and colleagues. Physical long-term conditions and psychological treatment outcomes in NHS Talking Therapies. 2026.
  3. NHS England. Talking Therapies annual report, 2025/26.
  4. NICE NG222. Depression in adults: treatment and management.
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care